Molecular Pharmacology Stock Analysis
| MLPH Stock | USD 0.0001 0.00 0.00% |
Molecular Pharmacology is overvalued with Real Value of 9.6E-5 and Hype Value of 1.05E-4. The main objective of Molecular Pharmacology pink sheet analysis is to determine its intrinsic value, which is an estimate of what Molecular Pharmacology is worth, separate from its market price. There are two main types of Molecular Pharmacology's stock analysis: fundamental analysis and technical analysis.
The Molecular Pharmacology pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Molecular Pharmacology's ongoing operational relationships across important fundamental and technical indicators.
Molecular |
Molecular Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Molecular Pharmacology Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. Molecular Pharmacology Limited is a subsidiary of PharmaNet Group Limited. Molecular Pharmacology is traded on OTC Exchange in the United States.The quote for Molecular Pharmacology is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Molecular Pharmacology contact Jeffrey Edwards at 61 8 9443 3011 or learn more at http://www.mpl-usa.com.Molecular Pharmacology Investment Alerts
| Molecular Pharmacology generated a negative expected return over the last 90 days | |
| Molecular Pharmacology has high historical volatility and very poor performance | |
| Molecular Pharmacology has some characteristics of a very speculative penny stock | |
| Molecular Pharmacology has a very high chance of going through financial distress in the upcoming years | |
| Molecular Pharmacology currently holds 175.33 K in liabilities. Molecular Pharmacology has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Molecular Pharmacology until it has trouble settling it off, either with new capital or with free cash flow. So, Molecular Pharmacology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Molecular Pharmacology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Molecular to invest in growth at high rates of return. When we think about Molecular Pharmacology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (116.93 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Molecular Pharmacology currently holds about 1.52 K in cash with (105.41 K) of positive cash flow from operations. |
Molecular Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 26.77 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Molecular Pharmacology's market, we take the total number of its shares issued and multiply it by Molecular Pharmacology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of December, Molecular Pharmacology secures the Standard Deviation of 11.07, risk adjusted performance of (0.07), and Mean Deviation of 2.66. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Molecular Pharmacology, as well as the relationship between them.Molecular Pharmacology Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Molecular Pharmacology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Molecular Pharmacology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Molecular Pharmacology Predictive Daily Indicators
Molecular Pharmacology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Molecular Pharmacology pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Relative Strength Index | 5.64 |
Molecular Pharmacology Forecast Models
Molecular Pharmacology's time-series forecasting models are one of many Molecular Pharmacology's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Molecular Pharmacology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Molecular Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Molecular Pharmacology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Molecular shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Molecular Pharmacology. By using and applying Molecular Pink Sheet analysis, traders can create a robust methodology for identifying Molecular entry and exit points for their positions.
Molecular Pharmacology Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. Molecular Pharmacology Limited is a subsidiary of PharmaNet Group Limited. Molecular Pharmacology is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Molecular Pharmacology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Complementary Tools for Molecular Pink Sheet analysis
When running Molecular Pharmacology's price analysis, check to measure Molecular Pharmacology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Pharmacology is operating at the current time. Most of Molecular Pharmacology's value examination focuses on studying past and present price action to predict the probability of Molecular Pharmacology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Pharmacology's price. Additionally, you may evaluate how the addition of Molecular Pharmacology to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |